eMed® is the leader in Population Health GLP-1/GIP program and chronic care management related to obesity and type 2 diabetes. eMed Empathetic AI™ Population Health GLP-1/GIP Program reduces the cost of your baseline GLP-1/GIP program by up to 50% and enables auditable ROI through cost avoidance and improved population health. eMed guarantees participant adherence, reduces costly ancillary medical services, and lowers medication spend. The program provides instant access to live care with no appointments ever.